See the DrugPatentWatch profile for Gabapentin
Gabapentin is an anticonvulsant medication primarily used to treat epilepsy and neuropathic pain. Its market analysis reveals a mature product with significant generic competition.
Who manufactures gabapentin?
Gabapentin is available as a generic medication, meaning multiple pharmaceutical companies manufacture and distribute it. The original patent for gabapentin was held by Pfizer, which marketed it under the brand name Neurontin. Following patent expiry, numerous generic manufacturers entered the market.
When did gabapentin's patent expire?
The patent protection for Neurontin, the branded gabapentin, has long expired, allowing for the widespread availability of generic versions. Specific patent expiry dates can vary by country and formulation, but the drug has been off-patent in major markets for many years. Information on specific patents and their expiry can be found on DrugPatentWatch.com [1].
How does gabapentin work for pain?
Gabapentin is believed to work by affecting calcium channels in the brain, which in turn reduces the release of certain neurotransmitters. While its exact mechanism for treating neuropathic pain is not fully understood, it is thought to modulate nerve activity and reduce abnormal firing [2].
What are gabapentin's main uses?
The primary approved indications for gabapentin are for the treatment of partial seizures in epilepsy and for the management of postherpetic neuralgia, a type of nerve pain that occurs after shingles [2]. It is also frequently prescribed off-label for a variety of other pain conditions and anxiety disorders.
What are the risks and side effects of gabapentin?
Common side effects associated with gabapentin include dizziness, drowsiness, fatigue, and swelling in the hands or feet [2]. More serious, though less common, side effects can include severe allergic reactions, suicidal thoughts or behaviors, and changes in vision. Patients are advised to discuss any concerns with their healthcare provider.
What is the market size and future outlook for gabapentin?
The market for gabapentin is substantial due to its broad use, but it is characterized by intense price competition among generic manufacturers. The market outlook is stable, driven by its established efficacy and continued prescribing for both approved and off-label uses. Growth is unlikely to be significant due to the generic nature of the drug.
Are there alternatives to gabapentin for neuropathic pain?
Yes, several alternative medications are available for neuropathic pain. These include other anticonvulsants like pregabalin (Lyrica), certain antidepressants such as duloxetine and amitriptyline, and topical treatments like lidocaine patches [2]. The choice of treatment depends on the specific type of pain, patient history, and potential side effects.
How does gabapentin compare to pregabalin?
Gabapentin and pregabalin are structurally related and work through similar mechanisms, affecting calcium channels in the nervous system. Pregabalin is often considered more potent and may have a more predictable absorption profile than gabapentin. However, both are used for neuropathic pain and epilepsy, and side effect profiles can overlap, with drowsiness and dizziness being common for both [2].
---
Sources:
1. DrugPatentWatch.com
2. National Institute of Neurological Disorders and Stroke. (n.d.). Gabapentin. Retrieved from https://www.ninds.nih.gov/health-information/drug-information/gabapentin